Innovating Works

H2020

Cerrada
HORIZON-HLTH-2022-STAYHLTH-01-01-two-sta...
Boosting mental health in Europe in times of change
ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several impacts of destination 1 “Staying healthy in a rapidly changing society”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to all of the following expected outcomes:
Sólo fondo perdido 7.0M €
Europeo
Mostrando 41 al 60 de 230 resultados
SmartCHANGE: AI-based long-term health risk evaluation for driving behaviour change strategies in children and yo... INSTITUT JOZEF STEFAN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Non-communicable diseases (NCDs) are the leading cause of death and healthcare expense. Common risk factors for many of them are obesity and...
2023-05-01 - 2027-04-30 | Financiado
SMILE: Supporting Mental Health in Young People: Integrated Methodology for cLinical dEcisions and evidence... FTKFORSCHUNGSINSTITUT FUR TELEKOMMUNIKATION UND KOOPERATION EV tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Anxiety disorders’ diagnosis, decision and treatment processes are still uncertain and inconsistent especially in a fast-evolving real world...
2023-05-01 - 2026-10-31 | Financiado
STRATIF-AI: Continuous stratification for improved prevention, treatment, and rehabilitation of stroke patients... LINKOPINGS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-12-01-two-stage State-of-the-art stratification today is based on machine-learning (ML) algorithms, trained on large cohort data. This has two main limitati...
2023-05-01 - 2027-04-30 | Financiado
GEREMY: Gene Therapy for treatment of rare inherited Arrhythmogenic Cardiomyopathy STICHTING NETHERLANDS HEART INSTITUTE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Development of a cure for rare cardiac diseases is a risky, costly and time-consuming process, which is hampered by insufficient insight int...
2023-05-01 - 2027-04-30 | Financiado
NOSEVAC: INNOVATIVE NASAL VACCINES TO PREVENT PATHOGEN COLONIZATION AND INFECTION IN THE UPPER RESPIRATORY TR... EUROPEAN VACCINE INITIATIVE E.V tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Bacterial and viral respiratory infections are a leading cause of morbidity and mortality worldwide. Streptococcus pneumoniae and Bordetella...
2023-05-01 - 2028-04-30 | Financiado
ARTILLERY: Artificial Intelligence for early detection of non-communicable disease risk in people with breast c... UNIVERSITAIR MEDISCH CENTRUM UTRECHT tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage The ultimate ambition of the ARTILLERY consortium is to enhance long term health of the growing population of breast cancer survivors by mak...
2023-05-01 - 2028-04-30 | Financiado
OBELISK: Fighting childhood obesity to stay healthy all over the life INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Obesity rates in late teens have increased in Europe from 6% in 1980 to 32%, with long-lasting effects on the prevalence of severe obesity,...
2023-05-01 - 2028-04-30 | Financiado
VASCUL-AID: DEVELOPING TRUSTWORTHY ARTIFICIAL INTELLIGENCE (AI)-DRIVEN TOOLS TO PREDICT VASCULAR DISEASE RISK AN... STICHTING AMSTERDAM UMC tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage The aim of VASCUL-AID is to predict the risk of cardiovascular events and progression of the vascular diseases Abdominal Aortic Aneurysm (AA...
2023-05-01 - 2029-04-30 | Financiado
IN-ARMOR: THERAPEUTIC EPIGENETIC ENHANCEMENT OF THE INNATE IMMUNITY TO EFFECTIVELY COMBAT ANTIMICROBIAL RESIS... HASKOLI ISLANDS tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Antimicrobial resistance (AMR) & multi-drug resistance, whereby pathogens evolve to resist antibiotic drugs, is designated by WHO one of the...
2023-05-01 - 2027-04-30 | Financiado
SPIDeRR: Stratification of Patients using advanced Integrative modeling of Data Routinely acquired for diagno... ACADEMISCH ZIEKENHUIS LEIDEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-12-01-two-stage Globally 1.Globally 1.71 billion people have musculoskeletal symptoms, the leading contributor to disability. Early disease stratification i...
2023-05-01 - 2028-04-30 | Financiado
PLACES: PLAsticity of perception in real and virtual spaCES UNIVERSITAET MUENSTER tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01-01 Space is fundamental to physical and perceptual reality, but physical and perceptual space are not the same. Perceptual space is created by...
2023-05-01 - 2027-04-30 | Financiado
MITI 2: Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease (IBD) Immunotherapy (MITI2) INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Our project focuses on the regulatory properties of a subset of microbiota-specific TR1-like regulatory T (Treg) cells, for which we have al...
2023-04-28 - 2027-04-30 | Financiado
ARTiDe: Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe) INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Type 1 diabetes (T1D) is an incurable disease, often starting in childhood, with a risk of devastating complications, premature mortality, a...
2023-04-27 - 2028-06-30 | Financiado
FIBROTARGET: Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseases KATHOLIEKE UNIVERSITEIT LEUVEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Fibrostenosis is the driving reason for the persistent need in bowel resections in inflammatory bowel diseases (IBD). Current IBD therapies...
2023-04-24 - 2028-03-31 | Financiado
Bootstrap: Boosting Societal Adaptation and Mental Health in a Rapidly Digitalizing Post Pandemic Europe INSTITUT CATALA DE LA SALUT tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-01-two-stage BACKGROUND: Adolescents are at particularly high risk for digital technology overuse, including in response to the COVID pandemic, and are t...
2023-04-21 - 2028-06-30 | Financiado
UltiMalVax: A Vaccine Targeting Eradication of Malaria EUROPEAN VACCINE INITIATIVE E.V tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-03-two-stage Malaria killed about 640 thousand people in 2020, largely young children in Africa. Rapid recent progress has led to two anti-sporozoite vac...
2023-04-21 - 2027-04-30 | Financiado
IMMUTOL: ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED... FONDAZIONE TELETHON ETS tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Autoimmune diseases are currently treated with immunosuppressive and supportive therapies, which dampen inflammation, but do not stop the ca...
2023-04-14 - 2027-04-30 | Financiado
eprObes: Preventing lifetime obesity by early risk factor identification prognosis and intervention CENTRO DE INVESTIGACION BIOMEDICA EN RED CIBER tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Obesity is one of the main population health threats worldwide, with a sustained increase in prevalence over the last decades and a constell...
2023-04-11 - 2028-04-30 | Financiado
STRATA-FIT: Stratification of Rheumatoid Arthritis: CompuTational models to personalise mAnagement strategies fo... UNIVERSITAIR MEDISCH CENTRUM UTRECHT tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-12-01-two-stage Difficult-to-treat rheumatoid arthritis (D2T RA) is an area of huge unmet medical need with major socio-economic consequences for patients a...
2023-04-07 - 2029-04-30 | Financiado
FLUTE: Federate Learning and mUlti-party computation Techniques for prostatE cancer INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-IND-13-02 The FLUTE project will advance and scale up data-driven healthcare by developing novel methods for privacy-preserving cross-border utilizati...
2023-04-04 - 2026-04-30 | Financiado